30-Second Takeaway
- SVS issues 13 updated, graded recommendations for blunt thoracic aortic injury, including timing, LSA, imaging, and anti-impulse therapy.
- After CLTI revascularization, antithrombotic escalation markedly increases bleeding without clear limb or cardiovascular benefit.
- Late open conversion after EVAR has similar perioperative risk to primary open repair but worse renal injury and long-term survival.
- Frailty strongly predicts upper-arm AVF abandonment, supporting individualized access planning and alternatives in severely frail patients.
- Center-level EVAR “wins above average” discriminates long-term performance and predicts future outcomes for program benchmarking.
Week ending March 28, 2026
Vascular surgery updates: trauma aorta, limb salvage, EVAR quality, and access planning
SVS updates evidence-based guidance for blunt thoracic aortic injury management
This focused SVS guideline update issues 13 graded recommendations for blunt thoracic aortic injury (BTAI) management. Key topics include indications and timing of definitive treatment, perioperative anticoagulation, left subclavian artery management, and imaging surveillance. The guideline emphasizes anti-impulse medical therapy and tailored strategies for patients with traumatic brain or solid organ injuries. It stresses collaborative decision-making among trauma and vascular teams and highlights persistent evidence gaps for future research.
Escalated antithrombotic regimens after CLTI revascularization increase bleeding without limb benefit
This single-center cohort compared post-discharge antithrombotic regimens after first-time lower extremity revascularization for chronic limb-threatening ischemia. Compared with aspirin monotherapy, prolonged DAPT, standard dual pathway inhibition, and triple therapy substantially increased gastrointestinal and major bleeding. Despite higher bleeding, there were no significant differences in myocardial infarction, stroke, primary patency, or major adverse limb events. These data argue against routine antithrombotic escalation beyond aspirin in CLTI revascularization patients absent compelling individualized indications.
Veterans with minor amputations remain at risk for later major limb loss
This national VA cohort examined major amputation risk among more than 62,000 veterans with diabetes and peripheral arterial disease. Among them, 1,327 had prior minor amputations and exhibited higher vascular risk profiles, including worse glycemic control and more prior revascularization. These patients were more likely to be Black or Native American, suggesting persistent disparities in limb outcomes. Findings indicate that a healed minor amputation does not eliminate major amputation risk and justify intensive surveillance and prevention.
References
Numbered in order of appearance. Click any reference to view details.
Additional Reads
Optional additional studies from this edition.